share_log

HC Wainwright & Co. Maintains Buy on Mind Medicine, Lowers Price Target to $35

HC Wainwright & Co. Maintains Buy on Mind Medicine, Lowers Price Target to $35

HC Wainwright & Co.維持對Mind Medicine的買入,將目標股價下調至35美元
Benzinga ·  05/10 15:39

HC Wainwright & Co. analyst Patrick Trucchio maintains Mind Medicine (NASDAQ:MNMD) with a Buy and lowers the price target from $75 to $35.

HC Wainwright & Co. 分析師帕特里克·特魯基奧維持Mind Medicine(納斯達克股票代碼:MNMD)的買入並將目標股價從75美元下調至35美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論